Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: We were worth more than 1$ after just two or three deals and now

RE: We were worth more than 1$ after just two or three deals and now

posted on Jul 14, 2006 12:39PM
That`s nonsens:

100 license of $10 million lead to a market cap of $1 Bio. Thats more than three times of our current market cap!!!!!!!!!!

This figures not include possible done reduction due to our buyback activities. Dividend was OK for longs staying with PTSC serveral years!

Would be nice to have this marke cap, so share price would be much higher :-)Furthermore market cap is just one criteria. Profitability and dividend rate (approx. 6%) is as much important as our market cap.

Good luck

S42005

Share
New Message
Please login to post a reply